Sarana Meditama Metropolitan

JKT:SAME · ID1000126303

Health Care Providers & ServicesSmall

360

Medium confidence — indicative

Value34

Profit price58

EV / EBIT18

Price / Owner Earnings98

Cash yield1

Owner Earnings Yield1

Dividend Yield1

Sales & asset price34

Price/Sales30

EV / Gross Profit12

Price/Book59

Quality37

Returns on capital15

Return on Capital13

Cash Return on Capital22

Return on Equity10

Profit margins20

EBIT Margin21

Gross Profitability19

Cash backing56

Cash Conversion94

Accruals54

Owner Earnings Margin21

Growth38

Sales growth43

Profit growth13

Profit Growth12

Long-Term EPS Growth14

Reinvestment39

Price momentum63

Safety49

Debt load51

Debt serviceability24

Refinancing47

Debt Payback1

Liquidity27

Sentiment40

Analyst ratings—

Expectations trend—

Market mood3

Value Creation4/20not creating value

Creates more value than its capital costs
Owner earnings growing
Owner earnings per share growing
Reinvests at strong returns
Solid earnings base

What this means

Sarana Meditama Metropolitan doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryIndonesia

IndustryHealth Care Providers & Services

SizeSmall

TypePublic Company

ExchangeIDX

Founded1985

Employees540

ISINID1000126303

Last UpdateApr 2, 2026

Indices

IDX Composite (Indonesia)

Themes

Chronic DiseasesHealth DiagnosticsOutpatient CareCardiovascularOrthopaedicsVaccinesOncologyHealth CareHospital

Description

PT Sarana Meditama Metropolitan Tbk is an entity engaged primarily in healthcare services and operates a network of hospitals and healthcare facilities that are integral to providing comprehensive medical care to the population. Business Segments T…

Analysis

Middle-of-the-road

PT Sarana Meditama Metropolitan Tbk is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is tepid and the balance sheet is adequate. The company scores 4/20 on our value-creation score: not creating value. Analyst sentiment is cautious.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250

2026

All-time high

Mar 2026

All-time low

Jun 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Sarana Meditama Metropolitan with its peers

Metro Healthcare Indonesia

JKT:CARE

CountryIndonesia

IndustryHealth Care Providers & Services

SizeSmall

Full Stock Analysis →

Business Alignment

SET:BIZ

CountryThailand

IndustryHealth Care Providers & Services

SizeSmall

Full Stock Analysis →

Aikchol Hospital

SET:AHC

CountryThailand

IndustryHealth Care Providers & Services

SizeSmall

Full Stock Analysis →

Rajthanee Hospital

SET:RJH

CountryThailand

IndustryHealth Care Providers & Services

SizeSmall

Full Stock Analysis →

Sejahteraraya Anugrahjaya

JKT:SRAJ

CountryIndonesia

IndustryHealth Care Providers & Services

SizeMedium

Full Stock Analysis →

Mahachai Hospital

SET:M-CHAI

CountryThailand

IndustryHealth Care Providers & Services

SizeSmall

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →